Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
The starving toddler has been taken into care following the incident in Chile - but it is thought the dog may well have saved his life.
The contract that set the Beatles on their way to superstardom is to go up for sale for the first time, and could fetch as much as £500,000.
The shortest man ever to have been measured has died aged 75, Guinness World Records has announced.